Innovation Pharmaceuticals Inc (IPIX)

[petemantx]

The most important part of the PR IMO:

"The lead researchers at both the RBL and at the PHRI have informed the Company they plan to submit their findings, separately, upon completion of in vitro testing, for peer-review publication. "

"Longer-term objectives include potentially performing additional research to develop Brilacidin as a broad-spectrum antiviral, with possible application beyond coronaviruses, e.g., treating other viruses, such as encephalitic alphaviruses and filoviruses."

Without a doubt ALL investigating bodies are finding exceptional results - you don't publish for peer-review failures and you don't expand a drug for broad-spectrum analysis unless it is doing well across the board.

News couldn't be better!!